Sign inGet started

Principi Anthony

Insider CIK 1347187 · CBLI Director · IMMY Director · EGL Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-3012,690— $089,225SEC↗
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-3017,006— $017,006SEC↗
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-309,715— $026,721SEC↗
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-3034,091— $060,812SEC↗
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-3015,723— $076,535SEC↗
HROW HARROW HEALTH, INC. M Exercise deriv2020-09-282020-09-304,573— $093,798SEC↗
HROW HARROW HEALTH, INC. M Exercise2020-09-282020-09-3093,798— $093,798SEC↗
HROW HARROW HEALTH, INC. A Award deriv2020-06-042020-06-0817,006— $017,006SEC↗
HROW HARROW HEALTH, INC. A Award deriv2019-06-262019-06-289,715— $09,715SEC↗
EGL Engility Holdings, Inc. D To issuer deriv2019-01-142019-01-143,529— $00SEC↗
EGL Engility Holdings, Inc. D To issuer deriv2019-01-142019-01-143,573— $00SEC↗
EGL Engility Holdings, Inc. D To issuer2019-01-142019-01-1418,536— $00SEC↗
EGL Engility Holdings, Inc. M Exercise deriv2019-01-112019-01-14177— $00SEC↗
EGL Engility Holdings, Inc. M Exercise deriv2019-01-112019-01-143,971— $00SEC↗
EGL Engility Holdings, Inc. M Exercise deriv2019-01-112019-01-144,284— $00SEC↗
EGL Engility Holdings, Inc. M Exercise2019-01-112019-01-144,284— $018,359SEC↗
EGL Engility Holdings, Inc. M Exercise2019-01-112019-01-14177— $018,536SEC↗
EGL Engility Holdings, Inc. M Exercise2019-01-112019-01-143,971— $014,075SEC↗
IMMY Imprimis Pharmaceuticals, A Award deriv2018-06-292018-07-0234,091— $034,091SEC↗
EGL Engility Holdings, Inc. A Award deriv2018-05-242018-05-293,971— $03,971SEC↗
EGL Engility Holdings, Inc. A Award2018-02-082018-02-09814— $010,104SEC↗
IMMY Imprimis Pharmaceuticals, A Award deriv2017-06-132017-06-1515,723— $015,723SEC↗
EGL Engility Holdings, Inc. A Award deriv2017-05-252017-05-303,573— $03,573SEC↗
IMMY Imprimis Pharmaceuticals, A Award deriv2016-06-102016-06-1412,690— $012,690SEC↗
EGL Engility Holdings, Inc. A Award deriv2016-05-262016-05-274,284— $04,284SEC↗
IMMY Imprimis Pharmaceuticals, A Award2015-09-012015-09-034,573— $04,573SEC↗
EGL Engility Holdings, Inc. A Award deriv2015-05-212015-06-113,529— $03,529SEC↗
CBLI CLEVELAND BIOLABS INC A Award deriv2015-04-222015-04-2416,000— $016,000SEC↗
EGL Engility Holdings, Inc. A Award deriv2015-03-182015-03-20177— $0177SEC↗
CBLI CLEVELAND BIOLABS INC A Award2015-01-082015-01-1237,947$0.30 $11.4K52,419SEC↗
CBLI CLEVELAND BIOLABS INC A Award deriv2014-06-112014-06-1335,000— $035,000SEC↗
EGL Engility Holdings, Inc. A Award2014-05-222014-05-231,965— $09,290SEC↗
CBLI CLEVELAND BIOLABS INC A Award2013-06-192013-06-2114,472— $014,472SEC↗
CBLI CLEVELAND BIOLABS INC A Award deriv2013-06-142013-06-1835,000— $035,000SEC↗
EGL Engility Holdings, Inc. A Award2013-05-232013-05-283,083— $07,325SEC↗
CBLI CLEVELAND BIOLABS INC A Award deriv2013-04-222013-04-2415,000— $015,000SEC↗
EGL Engility Holdings, Inc. A Award2012-07-182012-07-204,242— $04,242SEC↗